Work

Data Supplement from Enhancing Reproducibility in Cancer Drug Screening: How Do We Move Forward?

Year: 2023

Type: other

Abstract: Comparison of experimental protocols used in CGP and CCLE. Description of the major potential source of variability in phenotypic measurements between CGP and CCLE phenotype, due to differences in detection assay, quality assurance of screening plates, controls, and measures of drug potency (IC50).

DOI: 10.1158/0008-5472.22403684

Authors: Christos Hatzis, Philippe L. Bedard, Nicolai J. Birkbak, Andrew H. Beck, Hugo J.W.L. Aerts, David F. Stern, Leming Shi, Robert Clarke, John Quackenbush, Benjamin Haibe-Kains

Language: English

Topic: Computational Drug Discovery Methods

Subfield: Computational Theory and Mathematics

Field: Computer Science

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361811075

Cites:

Cited by:

Related to: 10